Veterinary Psychopharmacology.

Intro -- Title Page -- Copyright Page -- Contents -- Contributors -- Preface -- Acknowledgments -- Part I Principles of Veterinary Psychopharmacology -- Chapter 1 General Principles of Psychopharmacology -- Drug Action -- Dose Dependence of Drug Interaction with Receptors -- Structural Features of the Central Nervous System (CNS) and Neurotransmission -- Biogenic Amine Neurotransmitters and Affective Disorders -- References -- Chapter 2 Amino Acid Neurotransmitters: Glutamate, GABA, and the Pharmacology of Benzodiazepines -- Introduction -- Glutamatergic Synapses -- Pharmacology of Ketamine and Tiletamine -- GABAergic Synapses -- References -- Chapter 3 Biogenic Amine Neurotransmitters: Serotonin -- Introduction -- The Biogenic Amines -- Serotonin -- References -- Chapter 4 Biogenic Amine Transmitters: Acetylcholine, Norepinephrine, and Dopamine -- Acetylcholine -- Norepinephrine -- Dopamine -- References -- Chapter 5 Neuropeptides: Opioids and Oxytocin -- Introduction -- Endogenous Opioid Peptides -- Oxytocin -- References -- Part II Practice of Veterinary Psychopharmacology -- Chapter 6 Introduction to Clinical Psychopharmacology for Veterinary Medicine -- Introduction -- Prescribing in the United States: The Animal Medicinal Drug Use Clarification Act (AMDUCA 1994) -- Cost -- Drug Selection -- Medicating the Patient -- Competition Animals -- Taking the Behavioral History -- The Behavioral Exam -- Duration of Treatment -- Limitations -- References -- Chapter 7 Benzodiazepines -- Action -- Overview of Indications -- Contraindications, Side Effects, and Adverse Events -- Overdose -- Clinical Guidelines -- Specific Medications -- I.  Alprazolam -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Discontinuation -- Other Information -- Effects Documented in Nonhuman Animals.

II. Chlordiazepoxide HC1 -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Discontinuation -- Other Information -- Effects Documented in Nonhuman Animals -- III. Clonazepam -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Drug Interactions -- Overdose -- Doses in Nonhuman Animals -- Discontinuation -- Other Information -- Effects Documented in Nonhuman Animals -- IV. Clorazepate Dipotassium -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Dependence -- Overdose -- Doses in Nonhuman Animals -- Effects Documented in Nonhuman Animals -- V. Diazepam -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Discontinuation -- Other -- Effects Documented in Nonhuman Animals -- VI. Flurazepam Hydrochloride -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Effects Documented in Nonhuman Animals -- VII. Lorazepam -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Discontinuation -- Effects Documented in Nonhuman Animals -- VIII. Oxazepam -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Discontinuation -- Other Information -- Effects Documented in Nonhuman Animals -- IX. Triazolam -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Effects Documented in Nonhuman Animals -- Important Information for Owners of Pets Being Placed on Any Benzodiazepine -- References -- Chapter 8 Selective Serotonin Reuptake Inhibitors -- Action -- Overview of Indications.

Contraindications, Side Effects, and Adverse Events -- Adverse Drug Interactions -- Overdose -- Clinical Guidelines -- Specific Medications -- I. Citalopram Hydrobromide -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Other Information -- Effects Documented in Nonhuman Animals -- II. Fluoxetine Hydrochloride -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Discontinuation of Fluoxetine -- Other Information -- Effects Documented in Nonhuman Animals -- III. Fluvoxamine -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Other Information -- Effects Documented in Nonhuman Animals -- IV. Paroxetine Hydrochloride -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Discontinuation of Paroxetine -- Other Information -- Effects Documented in Nonhuman Animals -- V. Sertraline Hydrochloride -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Other Information -- Effects Documented in Nonhuman Animals -- VI. Escitalopram Oxalate -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Other Information -- Effects Documented in Nonhuman Animals -- Important Information for Owners of Pets Being Placed on Any SSRI -- References -- Chapter 9 Miscellaneous Serotonergic Agents -- Introduction -- Azapirones -- Action -- Overview of Indications -- Contraindications, Side Effects, and Adverse Events -- Adverse Drug Interactions -- Overdose -- Clinical Guidelines -- Specific Medications -- I. Buspirone -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Other Information -- Effects Documented in Nonhuman Animals.

Serotonin Antagonist/Reuptake Inhibitors (SARIs) -- Action -- Overview of Indications -- Contraindications, Side Effects, and Adverse Events -- Adverse Drug Interactions -- Overdose -- Clinical Guidelines -- Specific Medications -- I. Trazodone Hydrochloride -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Other Information -- Effects Documented in Nonhuman Animals -- Note -- References -- Chapter 10 Anticonvulsants and Mood Stabilizers -- Action -- Overview of Indications -- Clinical Guidelines -- Specific Medications -- I. Carbamazepine -- Clinical Pharmacology -- Side Effects -- Effects in Non‐human Animals -- II. Gabapentin -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Doses in Nonhuman Animals -- Other Information -- Effects Documented in Non‐human Animals -- Cattle -- III. Pregabalin -- Clinical Pharmacology -- Uses in Humans -- Side Effects -- Effects Documented in Nonhuman Animals -- References -- Chapter 11 Sympatholytic Agents -- Action -- Overview of Indications -- Contraindications, Side Effects, and Adverse Events -- Overdose -- Clinical Guidelines (Table 11.1) -- Specific Medications -- I. Clonidine -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Other Information -- Effects Documented in Nonhuman Animals -- II. Detomidine -- Clinical Pharmacology -- Use in Humans -- Contraindications -- Side Effects -- Other Information -- Effects Documented in Nonhuman Animals -- III. Dexmedetomidine -- Clinical Pharmacology -- Use in Humans -- Contraindications -- Side Effects -- Effects Documented in Nonhuman Animals -- IV. Propranolol -- Clinical Pharmacology -- Use in Humans -- Contraindications -- Side Effects -- Effects Documented in Nonhuman Animals -- References.

Chapter 12 N-Methyl-D-Aspartate (NMDA) Receptor Antagonists -- Action -- Overview of Indications -- Contraindications/Side Effects, and Adverse Events -- Clinical Guidelines -- Specific Medications -- I. Dextromethorphan -- Clinical Pharmacology -- Contraindications and Side Effects -- Other Information -- Effects Documented in Nonhuman Animals -- Horses -- II. Amantadine -- Clinical Pharmacology -- Use in Humans -- Contraindications -- Side Effects -- Overdose -- Effects Documented in Nonhuman Animals -- III. Memantine -- Clinical Pharmacology -- Use in Humans -- Side Effects -- Other Information -- Effects Documented in Nonhuman Animals -- IV. Huperzine A -- Clinical Pharmacology -- Use in Humans -- Overdose and Side Effects -- Effects Documented in Nonhuman Animals -- References -- Chapter 13 Monoamine Oxidase Inhibitors -- Action -- Overview of Indications -- Specific Medications -- I. Selegiline Hydrochloride -- Clinical Pharmacology -- Uses in Humans -- Contraindications -- Side Effects -- Overdose -- Discontinuation -- Other Information -- Effects Documented in Nonhuman Animals -- References -- Chapter 14 Antipsychotics -- Introduction -- Action -- Overview of Indications -- General Pharmacokinetics -- Contraindications, Side Effects, and Adverse Events -- Overdose -- Clinical Guidelines -- Specific Medications -- I. Acepromazine Maleate -- Clinical Pharmacology -- Indications -- Contraindications -- Side Effects -- Adverse Drug Interactions -- Overdose -- Doses in Nonhuman Animals -- Effects Documented in Nonhuman Animals -- II. Azaperone -- Clinical Pharmacology -- Indications -- Doses in Nonhuman Animals -- III. Chlorpromazine -- Clinical Pharmacology -- Uses in Humans -- Indications in Veterinary Medicine -- Contraindications -- Side Effects -- Effects Documented in Nonhuman Animals -- IV. Clozapine -- Clinical Pharmacology.

Uses in Humans.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.